Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Shorted: Short Interest Down 41.2% in September

Sino Biopharmaceutical (OTCMKTS:SBMFF) was the target of a large decrease in short interest in the month of September. As of September 15th, there was short interest totaling 15,082,316 shares, a decrease of 41.2% from the August 31st total of 25,660,865 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 530 shares, the short-interest ratio is presently 28,457.2 days.

Sino Biopharmaceutical Stock Performance

OTCMKTS:SBMFF remained flat at $0.70 during midday trading on Wednesday. 2,000 shares of the company were exchanged, compared to its average volume of 198. Sino Biopharmaceutical has a 1-year low of $0.59 and a 1-year high of $1.07. The business has a fifty day moving average price of $0.68 and a two-hundred day moving average price of $0.69.

Sino Biopharmaceutical Company Profile

Sino Biopharmaceutical Limited is a China-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of medicines. The company offers prescription drugs and other pharmaceutical products across areas including oncology, liver disease, respiratory conditions, digestive disorders, cardiovascular disease and orthopedics.

Its business includes generic medicines, innovative therapies, biologic products and traditional Chinese medicine. Key operating subsidiaries and research units include Chia Tai Tianqing Pharmaceutical Group, which has been associated with the development and commercialization of oncology and hepatology treatments, as well as other companies focused on pharmaceutical research, manufacturing and distribution.

Established in 2000, Sino Biopharmaceutical primarily serves the Chinese pharmaceutical market and has pursued international development and commercialization opportunities for selected products.